====== BIOMARKERS with Identifiers (Test:ID) ======


===== Breast Biomarkers =====
<WRAP div width-100%>
^ Biomarker ^ Assay Purpose ^ Drug(s) ^ Diagnostic Test ^ Test ID ^
| **PD-L1** | Triple Negative Breast Cancer (TNBC) | Pembrolizumab | PDL1 Dako 22C3 %%PharmDX%% | [[PDL1TNBC22C3PEMBRO|PDL1TNBC22C3PEMBRO]] |
</WRAP>

===== Gastrointestinal Biomarkers =====
<WRAP div width-100%>
^ Biomarker ^ Assay Purpose ^ Drug(s) ^ Diagnostic Test ^ Test ID ^
| **PD-L1** | Gastric, GEJ, esophageal adenocarcinoma; ESCC | Pembrolizumab, Nivolumab | PDL1 Dako 22C3 %%PharmDX%% | [[PDL1UPPERGIMARCH2026|PDL1UPPERGIMARCH2026]]  |
| **Claudin 18.2** | Gastric or GEJ adenocarcinoma | Zolbetuximab | VENTANA CLDN18 (43-14A) %%RxDx%% | [[BMCLAUDIN18|BMCLAUDIN18]] |
</WRAP>

===== Gyne Biomarkers =====
<WRAP div width-100%>
^ Biomarker ^ Assay Purpose ^ Drug(s) ^ Diagnostic Test ^ Test ID ^
| **PD-L1** | Cervical cancer (SCC and Adenocarcinoma) | Pembrolizumab | PDL1 Dako 22C3 %%PharmDX%% | [[PDL1CERVIX | PDL1CERVIX]] |
| **CEP17 SISH** | Ploidy Analysis | N/A | VENTANA Inform Chromosome 17 probe | [[MOLARCEP17.docx | MOLARCEP17]] |
</WRAP>


===== Head & Neck Biomarkers =====
<WRAP div width-100%>
^ Biomarker ^ Assay Purpose ^ Drug(s) ^ Diagnostic Test ^ Test ID ^
| **PD-L1** | **Advanced** HNSCC | Pembrolizumab | PDL1 Dako 22C3 %%PharmDX%% | [[PDL1HNSCC22C3PEMBRO.docx | PDL1HNSCC22C3PEMBRO]] |
| **PD-L1** | **Resectable** HNSCC | Pembrolizumab as **Neoadjuvant** | PDL1 Dako 22C3 %%PharmDX%% | [[PDL1HNSCCNEOADPEMBRO.docx | PDL1HNSCCNEOADPEMBRO]] |
</WRAP>


===== Lung Biomarkers =====
<WRAP div width-100%>
^ Biomarker ^ Assay Purpose ^ Drug(s) ^ Diagnostic Test ^ Test ID ^
| **PD-L1** | NSCLC stage IIIb to IV | Pembrolizumab | PDL1 22C3 | [[PDL1NSCLCPEMBRO22C3.docx | PDL1NSCLCPEMBRO22C3]] |
| **PD-L1** | NSCLC stage II to IIIA | Atezolizumab as **Adjuvant** | PDL1 SP263 | [[PDL1NSCLCATEZOSP263.docx | PDL1NSCLCATEZOSP263]] |
| **ALK** | NSCLC | alectinib, lorlatinib | ALK OTI1A4 | [[LUALKNEW.docx | LUALKNEW]] |
</WRAP>

===== Agnostic Biomarkers and miscellaneous =====
<WRAP div width-100%>
^ Biomarker ^ Assay Purpose ^ Drug(s) ^ Diagnostic Test ^ Test ID ^
| **pan-TRK** | Any primary | TRK inhibitors (Larotrectinib) | pan-TRK | [[PANTRK | PANTRK]] |
| **PD-L1 IHC NON-REPORTABLE** | Any primary | NA | Any clone | [[MDHPDL1NONREPORTABLE | MDHPDL1NONREPORTABLE]] |
</WRAP>

[[Summary List|Summary List]]